BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schnelldorfer T, Torres VE, Zakaria S, Rosen CB, Nagorney DM. Polycystic liver disease: a critical appraisal of hepatic resection, cyst fenestration, and liver transplantation. Ann Surg. 2009;250:112-118. [PMID: 19561475 DOI: 10.1097/sla.0b013e3181ad83dc] [Cited by in Crossref: 102] [Cited by in F6Publishing: 85] [Article Influence: 7.8] [Reference Citation Analysis]
Number Citing Articles
1 Duijzer R, Barten TRM, Staring CB, Drenth JPH, Gevers TJG. Treatment of Polycystic Liver Disease: Impact on Patient-reported Symptom Severity and Health-related Quality of Life. J Clin Gastroenterol 2022;56:731-9. [PMID: 35997709 DOI: 10.1097/MCG.0000000000001749] [Reference Citation Analysis]
2 Han P, Shi R, Yang L, Zhang Y. Treatment of bile leakage after partial hepatectomy of schnelldorfer type C polycystic liver using endoscopic retrograde cholangiopancreatography. Asian J Surg 2022:S1015-9584(22)01032-6. [PMID: 35963703 DOI: 10.1016/j.asjsur.2022.07.083] [Reference Citation Analysis]
3 Yoo JJ, Jo HI, Jung EA, Lee JS, Kim SG, Kim YS, Kim BK. Evidence of nonsurgical treatment for polycystic liver disease. Ther Adv Chronic Dis 2022;13:20406223221112563. [PMID: 35898920 DOI: 10.1177/20406223221112563] [Reference Citation Analysis]
4 Sharbidre K, Zahid M, Venkatesh SK, Bhati C, Lalwani N. Imaging of fibropolycystic liver disease. Abdom Radiol (NY) 2022. [PMID: 35670875 DOI: 10.1007/s00261-022-03565-7] [Reference Citation Analysis]
5 European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu., European Association for the Study of the Liver. EASL Clinical Practice Guidelines on management of Cystic Liver Diseases. J Hepatol 2022:S0168-8278(22)00347-6. [PMID: 35728731 DOI: 10.1016/j.jhep.2022.06.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Roediger R, Dieterich D, Chanumolu P, Deshpande P. Polycystic Kidney/Liver Disease. Clinics in Liver Disease 2022. [DOI: 10.1016/j.cld.2022.01.009] [Reference Citation Analysis]
7 Akuzawa D, Uchida Y, Ishimura T, Kakita H, Endo T, Matsuzaki N, Terajima H, Tsukamoto T. Polycystic liver disease with lethal abdominal wall rupture: a case report. J Med Case Rep 2021;15:421. [PMID: 34340688 DOI: 10.1186/s13256-021-02964-6] [Reference Citation Analysis]
8 Une N, Fujio A, Mitsugashira H, Kanai N, Saitoh Y, Ohta M, Sasaki K, Miyazawa K, Kashiwadate T, Nakanishi W, Tokodai K, Miyagi S, Unno M, Kamei T. Laparoscopic liver cyst fenestration with real-time indocyanine green fluorescence-guided surgery: a case report. J Surg Case Rep 2021;2021:rjab196. [PMID: 34025978 DOI: 10.1093/jscr/rjab196] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Alsager M, Neong SF, Gandhi R, Teriaky A, Tang E, Skaro A, Qumosani K, Lilly L, Galvin Z, Selzner N, Bhat MP, Puka K, Brahmania M. Liver transplantation in adult polycystic liver disease: the Ontario experience. BMC Gastroenterol 2021;21:115. [PMID: 33750299 DOI: 10.1186/s12876-021-01703-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Gomez A, Wisneski AD, Luu HY, Hirose K, Roberts JP, Hirose R, Freise CE, Nakakura EK, Corvera CU. Contemporary Management of Hepatic Cyst Disease: Techniques and Outcomes at a Tertiary Hepatobiliary Center. J Gastrointest Surg 2021;25:77-84. [PMID: 33083858 DOI: 10.1007/s11605-020-04821-1] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
11 Ariizumi SI, Kotera Y, Yamashita S, Omori A, Kato T, Shibuya G, Egawa H, Yamamoto M. Debulking of giant liver hemangiomas with severe symptoms: a case report. Surg Case Rep 2020;6:195. [PMID: 32748049 DOI: 10.1186/s40792-020-00960-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Hanaki T, Yagyu T, Uchinaka E, Morimoto M, Watanabe J, Tokuyasu N, Takano S, Sakamoto T, Honjo S, Fujiwara Y. Avoidance of bile duct injury during laparoscopic liver cyst fenestration using indocyanine green: A case report. Clin Case Rep 2020;8:1419-24. [PMID: 32884766 DOI: 10.1002/ccr3.2840] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
13 Li AY, Bergquist JR, August AT, Dua MM, Poultsides GA, Visser BC. Laparoscopic hepatic lobectomy for symptomatic polycystic liver disease. HPB (Oxford) 2021;23:56-62. [PMID: 32451237 DOI: 10.1016/j.hpb.2020.04.010] [Reference Citation Analysis]
14 Bernts LHP, Neijenhuis MK, Edwards ME, Sloan JA, Fischer J, Smoot RL, Nagorney DM, Drenth JPH, Hogan MC. Symptom relief and quality of life after combined partial hepatectomy and cyst fenestration in highly symptomatic polycystic liver disease. Surgery 2020;168:25-32. [PMID: 32402542 DOI: 10.1016/j.surg.2020.02.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
15 Zhang ZY, Wang ZM, Huang Y. Polycystic liver disease: Classification, diagnosis, treatment process, and clinical management. World J Hepatol 2020; 12(3): 72-83 [PMID: 32231761 DOI: 10.4254/wjh.v12.i3.72] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
16 Zhang Z, Hu K, Yang J, Zhou Y, Wang Z, Huang Y. Severe polycystic liver diseases: hepatectomy or waiting for liver transplantation?: Two case reports. Medicine (Baltimore) 2019;98:e18176. [PMID: 31804334 DOI: 10.1097/MD.0000000000018176] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
17 Bernts LHP, Drenth JPH, Tjwa ETTL. Management of portal hypertension and ascites in polycystic liver disease. Liver Int. 2019;39:2024-2033. [PMID: 31505092 DOI: 10.1111/liv.14245] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
18 Serrano Rodriguez P, Barritt AS IV, Gerber DA, Desai CS. Liver Transplant for Unusually Large Polycystic Liver Disease: Challenges and Pitfalls. Case Rep Transplant 2018;2018:4863187. [PMID: 29487756 DOI: 10.1155/2018/4863187] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
19 Rajoriya N, Tripathi D, Leithead JA, Gunson BK, Lord S, Ferguson JW, Hirschfield GM. Portal hypertension in polycystic liver disease patients does not affect wait-list or immediate post-liver transplantation outcomes. World J Gastroenterol 2016; 22(45): 9966-9973 [PMID: 28018103 DOI: 10.3748/wjg.v22.i45.9966] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
20 Neijenhuis MK, Gevers TJ, Hogan MC, Kamath PS, Wijnands TF, van den Ouweland RC, Edwards ME, Sloan JA, Kievit W, Drenth JP. Development and Validation of a Disease-Specific Questionnaire to Assess Patient-Reported Symptoms in Polycystic Liver Disease. Hepatology 2016;64:151-60. [PMID: 26970415 DOI: 10.1002/hep.28545] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
21 Martinez-Perez A, Alberola-Soler A, Domingo-Del Pozo C, Pemartin-Comella B, Martinez-Lopez E, Vazquez-Tarragon A. Laparoscopic surgery and polycystic liver disease: Clinicopathological features and new trends in management. J Minim Access Surg 2016;12:265-70. [PMID: 27279400 DOI: 10.4103/0972-9941.169976] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
22 Chebib FT, Harmon A, Irazabal Mira MV, Jung YS, Edwards ME, Hogan MC, Kamath PS, Torres VE, Nagorney DM. Outcomes and Durability of Hepatic Reduction after Combined Partial Hepatectomy and Cyst Fenestration for Massive Polycystic Liver Disease. J Am Coll Surg. 2016;223:118-126.e1. [PMID: 27016902 DOI: 10.1016/j.jamcollsurg.2015.12.051] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
23 Gevers TJ, Nevens F, Torres VE, Hogan MC, Drenth JP. Alkaline phosphatase predicts response in polycystic liver disease during somatostatin analogue therapy: a pooled analysis. Liver Int 2016;36:595-602. [PMID: 26481454 DOI: 10.1111/liv.12986] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
24 Cecere N, Hakem S, Demoulin N, Hubert C, Jabbour N, Goffette P, Pirson Y, Morelle J. Weight loss in a patient with polycystic kidney disease: when liver cysts are no longer innocent bystanders. Acta Clin Belg 2015;70:369-71. [PMID: 25866379 DOI: 10.1179/2295333715Y.0000000024] [Reference Citation Analysis]
25 Jung DH, Hwang S, Ahn CS, Moon DB, Song GW, Kim KH, Ha TY, Park GC, Lee SG. Fenestration of liver cysts in polycystic liver disease to improve quality of life: a case report and literature review. Korean J Hepatobiliary Pancreat Surg 2015;19:40-6. [PMID: 26155276 DOI: 10.14701/kjhbps.2015.19.1.40] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
26 Chapman AB, Devuyst O, Eckardt KU, Gansevoort RT, Harris T, Horie S, Kasiske BL, Odland D, Pei Y, Perrone RD, Pirson Y, Schrier RW, Torra R, Torres VE, Watnick T, Wheeler DC; Conference Participants. Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int 2015;88:17-27. [PMID: 25786098 DOI: 10.1038/ki.2015.59] [Cited by in Crossref: 243] [Cited by in F6Publishing: 245] [Article Influence: 34.7] [Reference Citation Analysis]
27 Vernadakis S, Moris D, Mamarelis G, Fouzas I, Mathe Z, Kaiser G, Paul A, Sotiropoulos G. Single-center experience of transplantation for polycystic liver disease. Transplant Proc 2014;46:3209-11. [PMID: 25420861 DOI: 10.1016/j.transproceed.2014.09.158] [Reference Citation Analysis]
28 Casteleijn NF, Visser FW, Drenth JP, Gevers TJ, Groen GJ, Hogan MC, Gansevoort RT. A stepwise approach for effective management of chronic pain in autosomal-dominant polycystic kidney disease. Nephrol Dial Transplant. 2014;29 Suppl 4:iv142-iv153. [PMID: 25165181 DOI: 10.1093/ndt/gfu073] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
29 Hogan MC, Abebe K, Torres VE, Chapman AB, Bae KT, Tao C, Sun H, Perrone RD, Steinman TI, Braun W, Winklhofer FT, Miskulin DC, Rahbari-Oskoui F, Brosnahan G, Masoumi A, Karpov IO, Spillane S, Flessner M, Moore CG, Schrier RW. Liver involvement in early autosomal-dominant polycystic kidney disease. Clin Gastroenterol Hepatol 2015;13:155-64.e6. [PMID: 25111236 DOI: 10.1016/j.cgh.2014.07.051] [Cited by in Crossref: 74] [Cited by in F6Publishing: 64] [Article Influence: 9.3] [Reference Citation Analysis]
30 Kanaan N, Devuyst O, Pirson Y. Renal transplantation in autosomal dominant polycystic kidney disease. Nat Rev Nephrol. 2014;10:455-465. [PMID: 24935705 DOI: 10.1038/nrneph.2014.104] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 5.4] [Reference Citation Analysis]
31 Miskulin DC, Abebe KZ, Chapman AB, Perrone RD, Steinman TI, Torres VE, Bae KT, Braun W, Winklhofer FT, Hogan MC, Rahbari-Oskoui F, Moore CG, Flessner MF, Schrier RW; HALT-PKD Study. Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1-4: a cross-sectional study. Am J Kidney Dis 2014;63:214-26. [PMID: 24183837 DOI: 10.1053/j.ajkd.2013.08.017] [Cited by in Crossref: 64] [Cited by in F6Publishing: 65] [Article Influence: 7.1] [Reference Citation Analysis]
32 Abu-Wasel B, Walsh C, Keough V, Molinari M. Pathophysiology, epidemiology, classification and treatment options for polycystic liver diseases. World J Gastroenterol 2013; 19(35): 5775-5786 [PMID: 24124322 DOI: 10.3748/wjg.v19.i35.5775] [Cited by in CrossRef: 56] [Cited by in F6Publishing: 43] [Article Influence: 6.2] [Reference Citation Analysis]
33 Long-xian Z, Ai-wu L, Hua-dong Q, Jun C, Hui-jie J, Hong-bo J. Treatment of polycystic liver disease: a hypothesis, patient characteristics, short and long-term results. Annals of Hepatology 2013;12:782-90. [DOI: 10.1016/s1665-2681(19)31320-1] [Reference Citation Analysis]
34 Koutsampasopoulos K, Antoniadou E, Zoutis S, Iacovidis G, Burova O, Taplidis A. Neuroendocrine tumor in the liver of a patient with isolated polycystic liver disease: A case report and review of the literature. Oncol Lett 2013;5:1664-6. [PMID: 23761831 DOI: 10.3892/ol.2013.1233] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
35 Chun YS, House MG, Kaur H, Loyer EM, Paradis V, Vauthey JN. SSAT/AHPBA joint symposium on evaluation and treatment of benign liver lesions. J Gastrointest Surg 2013;17:636-44. [PMID: 23377783 DOI: 10.1007/s11605-013-2153-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
36 Gevers TJ, Drenth JP. Diagnosis and management of polycystic liver disease. Nat Rev Gastroenterol Hepatol. 2013;10:101-108. [PMID: 23296249 DOI: 10.1038/nrgastro.2012.254] [Cited by in Crossref: 113] [Cited by in F6Publishing: 95] [Article Influence: 12.6] [Reference Citation Analysis]
37 Chaudhary S, Qian Q. Acute abdomen and ascites as presenting features of autosomal dominant polycystic kidney disease. World J Hepatol 2012; 4(12): 394-398 [PMID: 23355918 DOI: 10.4254/wjh.v4.i12.394] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
38 Macutkiewicz C, Plastow R, Chrispijn M, Filobbos R, Ammori BA, Sherlock DJ, Drenth JP, O'Reilly DA. Complications arising in simple and polycystic liver cysts. World J Hepatol 2012; 4(12): 406-411 [PMID: 23355921 DOI: 10.4254/wjh.v4.i12.406] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
39 Gedaly R, Guidry P, Davenport D, Daily M, Ronsenau J, Shah M, Cooper MA, Hundley J. Peri-operative challenges and long-term outcomes in liver transplantation for polycystic liver disease. HPB (Oxford) 2013;15:302-6. [PMID: 23458516 DOI: 10.1111/j.1477-2574.2012.00579.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
40 Coelho-Prabhu N, Nagorney DM, Baron TH. ERCP for the treatment of bile leak after partial hepatectomy and fenestration for symptomatic polycystic liver disease. World J Gastroenterol 2012; 18(28): 3705-3709 [PMID: 22851862 DOI: 10.3748/wjg.v18.i28.3705] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
41 Linguraru MG, Sandberg JK, Jones EC, Petrick N, Summers RM. Assessing hepatomegaly: automated volumetric analysis of the liver. Acad Radiol 2012;19:588-98. [PMID: 22361033 DOI: 10.1016/j.acra.2012.01.015] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
42 Romeo M, Tous F, Loza Y, Torres M. [Surgical treatment of symptomatic polycystic liver disease, an uncommon problem without systematic approach]. Med Clin (Barc) 2012;138:457-8. [PMID: 21939998 DOI: 10.1016/j.medcli.2011.07.010] [Reference Citation Analysis]
43 Lee HF, Lu CL, Chang FY. A man with dyspnea and hepatomegaly. Gastroenterology 2010;139:732, 1066. [PMID: 20659458 DOI: 10.1053/j.gastro.2009.09.079] [Reference Citation Analysis]
44 Kobashi-margáin RA, Gutiérrez-grobe Y, Méndez-sánchez N. Hepatology Highlights. Annals of Hepatology 2010;9:249-50. [DOI: 10.1016/s1665-2681(19)31633-3] [Reference Citation Analysis]
45 Hogan MC, Norby SM. Evaluation and management of pain in autosomal dominant polycystic kidney disease. Adv Chronic Kidney Dis 2010;17:e1-e16. [PMID: 20439087 DOI: 10.1053/j.ackd.2010.01.005] [Cited by in Crossref: 56] [Cited by in F6Publishing: 45] [Article Influence: 4.7] [Reference Citation Analysis]
46 Hogan MC, Masyuk TV, Page LJ, Kubly VJ, Bergstralh EJ, Li X, Kim B, King BF, Glockner J, Holmes DR, Rossetti S, Harris PC, LaRusso NF, Torres VE. Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease. J Am Soc Nephrol. 2010;21:1052-1061. [PMID: 20431041 DOI: 10.1681/asn.2009121291] [Cited by in Crossref: 229] [Cited by in F6Publishing: 201] [Article Influence: 19.1] [Reference Citation Analysis]
47 . Current world literature. Curr Opin Organ Transplant 2010;15:254-61. [PMID: 20351662 DOI: 10.1097/MOT.0b013e328337a8db] [Reference Citation Analysis]
48 Qian Q. Isolated polycystic liver disease. Adv Chronic Kidney Dis 2010;17:181-9. [PMID: 20219621 DOI: 10.1053/j.ackd.2009.12.005] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
49 Harris PC, Rossetti S. Determinants of renal disease variability in ADPKD. Adv Chronic Kidney Dis 2010;17:131-9. [PMID: 20219616 DOI: 10.1053/j.ackd.2009.12.004] [Cited by in Crossref: 40] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
50 Pirson Y. Extrarenal manifestations of autosomal dominant polycystic kidney disease. Adv Chronic Kidney Dis 2010;17:173-80. [PMID: 20219620 DOI: 10.1053/j.ackd.2010.01.003] [Cited by in Crossref: 95] [Cited by in F6Publishing: 80] [Article Influence: 7.9] [Reference Citation Analysis]